GBP2
Basic information
Region (hg38): 1:89106132-89150456
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GBP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 39 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 39 | 4 | 0 |
Variants in GBP2
This is a list of pathogenic ClinVar variants found in the GBP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-89108192-T-C | not specified | Uncertain significance (Aug 01, 2024) | ||
1-89108195-G-A | not specified | Uncertain significance (Aug 15, 2023) | ||
1-89108225-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
1-89108281-C-T | not specified | Uncertain significance (Dec 10, 2024) | ||
1-89108282-G-A | not specified | Uncertain significance (Jun 28, 2024) | ||
1-89109698-C-G | not specified | Uncertain significance (Dec 07, 2024) | ||
1-89109713-C-T | not specified | Uncertain significance (Oct 16, 2024) | ||
1-89110206-G-T | not specified | Uncertain significance (Apr 22, 2022) | ||
1-89110232-T-A | not specified | Uncertain significance (Jan 14, 2025) | ||
1-89110251-T-G | not specified | Uncertain significance (May 30, 2023) | ||
1-89112476-A-T | not specified | Uncertain significance (Dec 20, 2024) | ||
1-89112539-C-T | not specified | Uncertain significance (Jun 21, 2023) | ||
1-89112557-G-A | not specified | Uncertain significance (Dec 13, 2022) | ||
1-89112582-C-G | not specified | Uncertain significance (Dec 06, 2024) | ||
1-89114002-A-G | Inherited susceptibility to mycobacterial diseases | Likely risk allele (-) | ||
1-89114024-T-C | not specified | Likely benign (Oct 14, 2021) | ||
1-89114066-T-C | not specified | Uncertain significance (Feb 21, 2024) | ||
1-89114098-C-A | not specified | Uncertain significance (Nov 13, 2024) | ||
1-89114149-T-C | not specified | Uncertain significance (Nov 09, 2024) | ||
1-89114165-C-T | not specified | Uncertain significance (May 03, 2023) | ||
1-89114173-G-T | not specified | Uncertain significance (Feb 21, 2025) | ||
1-89114192-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
1-89114228-C-A | not specified | Uncertain significance (Nov 15, 2024) | ||
1-89114266-T-C | not specified | Uncertain significance (Jan 26, 2025) | ||
1-89117015-C-T | not specified | Uncertain significance (Sep 17, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GBP2 | protein_coding | protein_coding | ENST00000370466 | 10 | 44325 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.03e-10 | 0.786 | 125672 | 0 | 76 | 125748 | 0.000302 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.107 | 312 | 317 | 0.983 | 0.0000162 | 3918 |
Missense in Polyphen | 85 | 95.611 | 0.88902 | 1251 | ||
Synonymous | -0.112 | 123 | 121 | 1.01 | 0.00000664 | 1084 |
Loss of Function | 1.60 | 19 | 28.1 | 0.675 | 0.00000153 | 321 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000355 | 0.000355 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000291 | 0.000290 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000754 | 0.000752 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes GTP to GMP in 2 consecutive cleavage reactions, but the major reaction product is GDP (PubMed:8706832). Exhibits antiviral activity against influenza virus. Promote oxidative killing and deliver antimicrobial peptides to autophagolysosomes, providing broad host protection against different pathogen classes (By similarity). {ECO:0000250|UniProtKB:P32455, ECO:0000269|PubMed:8706832}.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling
(Consensus)
Intolerance Scores
- loftool
- 0.875
- rvis_EVS
- 0.96
- rvis_percentile_EVS
- 90.15
Haploinsufficiency Scores
- pHI
- 0.155
- hipred
- N
- hipred_score
- 0.290
- ghis
- 0.442
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.945
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gbp2
- Phenotype
- immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- immune response;protein localization to nucleus;interferon-gamma-mediated signaling pathway;type I interferon signaling pathway;cellular response to interferon-gamma;cellular response to interleukin-1;cellular response to tumor necrosis factor
- Cellular component
- Golgi membrane;nucleus;nucleoplasm;cytoplasm;Golgi apparatus;cytosol;actin cytoskeleton;perinuclear region of cytoplasm
- Molecular function
- GTPase activity;protein binding;GTP binding;protein homodimerization activity